1. Pharmacologic management of trigeminal nerve injury after endodontic treatment: A retrospective analysis.
- Author
-
Park, Keun Jeong, Choi, Eunhye, Jung, Il Young, and Kim, Seong Taek
- Subjects
STEROIDS ,NONSTEROIDAL anti-inflammatory agents ,CUTANEOUS therapeutics ,COMBINATION drug therapy ,ACADEMIC medical centers ,ADENOSINE triphosphate ,TRIGEMINAL nerve ,TREATMENT effectiveness ,RETROSPECTIVE studies ,DESCRIPTIVE statistics ,VITAMIN B complex ,NUMBNESS ,ANTIDEPRESSANTS ,ROOT canal treatment ,MEDICAL records ,ACQUISITION of data ,NARCOTICS ,COMPARATIVE studies ,MAXILLARY nerve ,LIDOCAINE ,ANTICONVULSANTS - Abstract
Background: Trigeminal nerve injury following endodontic treatment, leading to unpleasant sensations or partial sensory loss in the face or oral mucosa, is uncommon but significant when it occurs. Objective: This study analysed the pharmacological management of trigeminal nerve injuries (TNI) in a university‐based hospital. Methods: We conducted a retrospective analysis of 47 patients who visited the Department of Orofacial Pain and Oral Medicine at Yonsei University Dental Hospital, Seoul, Korea, after TNI following endodontic procedures in primary clinics. Both objective tests and subjective evaluations, assessed the extent and duration of sensory injury during the initial visit. The patient's initial symptoms, presumed cause of TNI, referral delay (time interval between TNI and the first visit to our clinic), and medications were analysed to determine whether these factors affected the outcomes. Results: Most patients with TNI experienced dysesthesia with hypoesthesia (70.2%). The mandibular molars were predominantly affected (72.3%), with the inferior alveolar nerve (IAN), lingual nerve (LN), both IAN and LN, and maxillary nerve compromised in 83.0, 12.8, 2.1, and 2.1% of cases, respectively. Causes of TNI included local anaesthesia (29.8%), overfilling/over‐instrumentation (25.5%), endodontic surgery (17.0%), and unknown factors (27.7%). A shorter referral delay was associated with better outcomes, with an average delay of 8.6 weeks for symptom improvement compared with 44.1 weeks for no change. The medication regimens included steroids, NSAIDs, topical lidocaine, vitamin B complex, Adenosine Triphosphate (ATP), antiepileptics, antidepressants, and opioids administered alone or in combination, with a mean duration of 20.7 weeks. 53.2% of the patients reported improvement in their symptoms, 27.7% experienced no significant change, and 19.1% had unknown outcomes. Conclusions: Swift referral to an orofacial pain specialist is recommended for effective recovery in cases of TNI arising from endodontic treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF